Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2016 Mar;24(1):60-3.
doi: 10.4250/jcu.2016.24.1.60. Epub 2016 Mar 24.

Heart within a Heart

Affiliations
Case Reports

Heart within a Heart

Tarun Jain et al. J Cardiovasc Ultrasound. 2016 Mar.

Abstract

Device based closure of the left atrial appendage (LAA) has emerged as a viable approach for stroke prevention in atrial fibrillation (AF) patients with contraindications to chronic oral anticoagulation. One of the most feared complications is device related thrombus formation. We present a 66-year-old male with chronic AF who developed a life-threatening intracranial bleed on oral anti-coagulation. He subsequently underwent LAA closure using an Amplatzer muscular ventricular septal defect closure device for stroke prevention. However, he was found to have a large thrombus attached to the device a year later. We present a review of the various LAA closure devices, importance of periodic surveillance via echocardiography and management options to prevent this complication. Also, the case highlights the importance of contrast-enhance echocardiography in diagnosis of LAA closure device thrombus.

Keywords: Atrial fibrillation; Left atrial appendage; Transcatheter occlusion device.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1. Zoom in of atrium from apical four chamber view. Unable to appreciate thrombus in this view without the use of contrast.
Fig. 2
Fig. 2. Heart within a heart. Three chamber view showing a stalk with pedunculated thrombus (arrow).
Fig. 3
Fig. 3. Contrast-enhanced echocardiogram enhances view of thrombus (arrow).
Fig. 4
Fig. 4. Transesophageal echocardiogram confirms a large bi-lobed thrombus (arrows).
Fig. 5
Fig. 5. Transesophageal 3D image shows thrombus attached to ventricular septal defect occluder device (arrow).

References

    1. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, Carnethon MR, Dai S, de Simone G, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Greenlund KJ, Hailpern SM, Heit JA, Ho PM, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli A, Matchar DB, McDermott MM, Meigs JB, Moy CS, Mozaffarian D, Mussolino ME, Nichol G, Paynter NP, Rosamond WD, Sorlie PD, Stafford RS, Turan TN, Turner MB, Wong ND, Wylie-Rosett J American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation. 2011;123:e18–e209. - PMC - PubMed
    1. Blackshear JL, Odell JA. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann Thorac Surg. 1996;61:755–759. - PubMed
    1. Lardizabal JA, Sharma S. Mechanical approaches to stroke prevention in atrial arrhythmias. J Innov Cardiac Rhythm Manage. 2012;3:809–813.
    1. Holmes DR, Reddy VY, Turi ZG, Doshi SK, Sievert H, Buchbinder M, Mullin CM, Sick P PROTECT AF Investigators. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet. 2009;374:534–542. - PubMed
    1. Reddy VY, Möbius-Winkler S, Miller MA, Neuzil P, Schuler G, Wiebe J, Sick P, Sievert H. Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology) J Am Coll Cardiol. 2013;61:2551–2556. - PubMed

Publication types